Skip to content

axabio

Active
Public limited companyfounded 2024active for 2 yearsNieuwe dreef 2, 2620 Hemiksem, BelgiumKBO/BCE: BE 1011.997.238
Summary

The computed 12-month bankruptcy probability of axabio is 1.5% (moderate). The 2025 annual accounts show negative equity (-€652,510) and a net result of -€2.4m. Its solvency ranks better than 9% of 239 sector peers (NACE 72, financial year 2025). The company has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals.

Financials · financial year 2025, full format

Turnover
€384,292▲ 762%
2024 · €44,560
EBIT margin
Not meaningful: turnover is only a small part of operating income
Net result
-€2.4m▼ 2.6%
2024 · -€2.3m
Working capital
€560,427
2024 · -€70,585
Trend over the years

2024 to 2025, 2 financial years

The operating result stays negative: a loss of €2.5m in 2025 against €2.3m in 2024; the loss grows.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Turnover€0.4m 2025 Operating result-€2.5m 2025 Net result-€2.4m 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 72, Scientific research and development: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the financial year before
favourable unfavourable
Line20242025
Turnover€0.04m-€0.4m▲ 762%
Operating result-€2.3m--€2.5m▼ 9.1%
Net result-€2.3mbelow the sector's middle half--€2.4mbelow the sector's middle half▼ 2.6%
Equity€0.8mwithin the sector's middle half--€0.7mbelow the sector's middle half
Total assets€3.2mwithin the sector's middle half-€4.0mwithin the sector's middle half▲ 24.6%
Debt€2.4m-€4.6m▲ 93.7%
Working capital-€0.07mbelow the sector's middle half-€0.6mwithin the sector's middle half
Solvency25.2%within the sector's middle half--16.4%below the sector's middle half▼ 41.6pp
Current ratio0.78below the sector's middle half-2.21within the sector's middle half▲ 1.43
Return on assets (ROA)-72.3%below the sector's middle half--59.6%below the sector's middle half▲ 12.8pp
Staff (FTE)10.4within the sector's middle half-11.1within the sector's middle half▲ 6.7%
above within below the middle half of NACE 72, Scientific research and development: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €4.0m
Fixed assets €3.0m ▲ 0.6%
Current assets €1.0m ▲ 302%
Equity and liabilities
Equity-€652,510
Debt€4.6m
Equity is negative: debt (€4.6m) exceeds the balance-sheet total (€4.0m).
Key figures and ratios
2025 value · change against 2024
EBITDA
-€1.6m▼
2024 · -€1.5m
Cash flow
-€1.5m▲
2024 · -€1.6m
Quick ratio
1.75▲
2024 · 0.69
Interest coverage
-13.88▲
2024 · -42.00
Debt ≤ 1 year
€462,941▲
2024 · €325,297
Debt > 1 year
€4.2m▲
2024 · €2.1m
Staff costs
€1.1m▲
2024 · €635,211
No debt to equity: equity is negative, so debt divided by equity means nothing.
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 490 companies that looked in July 2024 the way this one looks now, 6.7% went bankrupt within 24 months and 88.8% are still going.

  • Small
  • 2 to 5 years old
  • negative equity
  • a loss of 10% of the balance sheet or more
6.7% went bankrupt
3.9% stopped otherwise
88.8% still going

A further 0.6% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 1.5% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 490 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 67 lines
Balance sheet Code20242025
Assets
Total assets20/58€3.2m€4.0m▲
Fixed assets21/28€2.9m€3.0m▲
Intangible fixed assets21€0.3m€0.7m▲
Tangible fixed assets22/27€2.6m€2.2m▼
Plant, machinery and equipment23€2.6m€2.2m▼
Furniture and vehicles24€0.008m€0.01m▲
Current assets29/58€0.3m€1.0m▲
Stocks and contracts in progress3€0.03m€0.2m▲
Stocks30/36€0.03m€0.2m▲
Raw materials and consumables30/31€0.03m€0.2m▲
Amounts receivable within one year40/41€0.1m€0.8m▲
Trade receivables40€0.04m€0.2m▲
Other amounts receivable41€0.09m€0.6m▲
Cash at bank and in hand54/58€0.09m€0.001m▼
Deferred charges and accrued income490/1€0.006m€0.02m▲
Equity and liabilities
Total equity and liabilities10/49€3.2m€4.0m▲
Equity10/15€0.8m-€0.7m▼
Contributions10/11€3.1m€3.1m=
Capital10€3.1m€3.1m=
Issued capital100€3.1m€3.1m=
Reserves13€0.04m€0.04m=
Non-distributable reserves130/1€0.02m€0.02m=
Legal reserve130€0.02m€0.02m=
Distributable reserves133€0.02m€0.02m=
Profit (loss) carried forward14-€2.3m-€4.7m▼
Investment grants15-€0.9m
Amounts payable17/49€2.4m€4.6m▲
Amounts payable after more than one year17€2.1m€4.2m▲
Financial debts170/4€2.1m€4.2m▲
Other loans174€2.1m€4.2m▲
Amounts payable within one year42/48€0.3m€0.5m▲
Financial debts43€0.01m€0.01m▲
Credit institutions430/8€0.01m€0.01m▲
Trade debts44€0.3m€0.4m▲
Suppliers440/4€0.3m€0.4m▲
Taxes, remuneration and social security45€0.02m€0.1m▲
Taxes450/3-€3
Remuneration and social security454/9€0.02m€0.1m▲
Other amounts payable47/48€0.002m€0▼
Income statement Code20242025
Operating income70/76A€0.3m€1.4m▲
Turnover70€0.04m€0.4m▲
Own construction capitalised72€0.3m€0.6m▲
Other operating income74€0.02m€0.2m▲
Non-recurring operating income76A€0.002m€0.2m▲
Operating charges60/66A€2.6m€3.8m▲
Goods for resale, raw materials and consumables60€0.1m€0.5m▲
Purchases600/8€0.1m€0.7m▲
Change in stocks: decrease (increase)609-€0.03m-€0.2m▼
Services and other goods61€1.1m€1.3m▲
Remuneration, social security and pensions62€0.6m€1.1m▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€0.7m€0.9m▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€0.002m€0▼
Other operating charges640/8€0.001m€0.001m▼
Operating profit (loss)9901-€2.3m-€2.5m▼
Financial income75/76B€381€0.2m▲
Recurring financial income75€381€0.2m▲
Other financial income752/9€381€0.2m▲
Financial charges65/66B€0.04m€0.1m▲
Recurring financial charges65€0.04m€0.1m▲
Debt charges650€0.04m€0.1m▲
Other financial charges652/9€0.002m€0.002m▲
Profit (loss) for the period before taxes9903-€2.3m-€2.4m▼
Profit (loss) for the period9904-€2.3m-€2.4m▼
Profit (loss) for the period to be appropriated9905-€2.3m-€2.4m▼
Appropriation of the result
Profit (loss) to be appropriated9906-€2.3m-€4.7m▼
Profit (loss) brought forward from the previous period14P--€2.3m
Social balance sheet
Average headcount (FTE)908710.411.1▲

The notes to these accounts (46 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20242025Change
Operating income70/76A€0.3m€1.4m▲ 319%
Turnover70€0.04m€0.4m▲ 762%
Own construction capitalised72€0.3m€0.6m▲ 116%
Other operating income74€0.02m€0.2m▲ 13×
Non-recurring operating income76A€0.002m€0.2m▲ 82×
Operating charges60/66A€2.6m€3.8m▲ 47.8%
Goods for resale, raw materials and consumables60€0.1m€0.5m▲ 450%
Purchases600/8€0.1m€0.7m▲ 458%
Change in stocks: decrease (increase)609-€0.03m-€0.2m▼ 485%
Services and other goods61€1.1m€1.3m▲ 14.2%
Remuneration, social security and pensions62€0.6m€1.1m▲ 78.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€0.7m€0.9m▲ 20.3%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€0.002m€0▼ 100%
Other operating charges640/8€0.001m€0.001m▼ 7.0%
Operating profit (loss)9901-€2.3m-€2.5m▼ 9.1%
Financial income75/76B€381€0.2m▲ 601×
Recurring financial income75€381€0.2m▲ 601×
Other financial income752/9€381€0.2m▲ 601×
Financial charges65/66B€0.04m€0.1m▲ 205%
Recurring financial charges65€0.04m€0.1m▲ 205%
Debt charges650€0.04m€0.1m▲ 215%
Other financial charges652/9€0.002m€0.002m▲ 23.8%
Profit (loss) for the period before taxes9903-€2.3m-€2.4m▼ 2.6%
Profit (loss) for the period9904-€2.3m-€2.4m▼ 2.6%
Profit (loss) for the period to be appropriated9905-€2.3m-€2.4m▼ 2.6%
Line20242025Change
Assets
Total assets20/58€3.2m€4.0m▲ 24.6%
Fixed assets21/28€2.9m€3.0m▲ 0.6%
Intangible fixed assets21€0.3m€0.7m▲ 145%
Tangible fixed assets22/27€2.6m€2.2m▼ 16.0%
Plant, machinery and equipment23€2.6m€2.2m▼ 16.2%
Furniture and vehicles24€0.008m€0.01m▲ 64.5%
Current assets29/58€0.3m€1.0m▲ 302%
Stocks and contracts in progress3€0.03m€0.2m▲ 585%
Stocks30/36€0.03m€0.2m▲ 585%
Raw materials and consumables30/31€0.03m€0.2m▲ 585%
Amounts receivable within one year40/41€0.1m€0.8m▲ 517%
Trade receivables40€0.04m€0.2m▲ 490%
Other amounts receivable41€0.09m€0.6m▲ 527%
Cash at bank and in hand54/58€0.09m€0.001m▼ 98.5%
Deferred charges and accrued income490/1€0.006m€0.02m▲ 174%
Equity and liabilities
Total equity and liabilities10/49€3.2m€4.0m▲ 24.6%
Equity10/15€0.8m-€0.7m-
Contributions10/11€3.1m€3.1m=
Capital10€3.1m€3.1m=
Issued capital100€3.1m€3.1m=
Reserves13€0.04m€0.04m=
Non-distributable reserves130/1€0.02m€0.02m=
Legal reserve130€0.02m€0.02m=
Distributable reserves133€0.02m€0.02m=
Profit (loss) carried forward14-€2.3m-€4.7m▼ 103%
Investment grants15-€0.9m-
Amounts payable17/49€2.4m€4.6m▲ 93.7%
Amounts payable after more than one year17€2.1m€4.2m▲ 102%
Financial debts170/4€2.1m€4.2m▲ 102%
Other loans174€2.1m€4.2m▲ 102%
Amounts payable within one year42/48€0.3m€0.5m▲ 42.3%
Financial debts43€0.01m€0.01m▲ 8.1%
Credit institutions430/8€0.01m€0.01m▲ 8.1%
Trade debts44€0.3m€0.4m▲ 21.8%
Suppliers440/4€0.3m€0.4m▲ 21.8%
Taxes, remuneration and social security45€0.02m€0.1m▲ 310%
Taxes450/3-€3-
Remuneration and social security454/9€0.02m€0.1m▲ 310%
Other amounts payable47/48€0.002m€0▼ 100%
Line20242025Change
Profit (loss) for the period9904-€2.3m-€2.4m▼ 2.6%
+ Depreciation and write-downs630€0.7m€0.9m▲ 20.3%
Operating cash flow (approximation)-€1.6m-€1.5m▲ 5.6%
Investment in fixed assets (approximation)--€0.9m-
Change in cash--€0.09m-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (2)
Financial year Type Filed Reference
31-12-2025 full format 19-06-2026 2026-00175885
31-12-2024 full format 05-06-2025 2025-00125227

Similar companies · same sector, comparable size

Of the 761 active companies whose main activity is research and development on biotechnology (NACE 72101), figures are known for 483. 154 are within a factor 10 of this headcount. These 5 are the closest to it. See the whole sector

Subsidies and aid

Flemish government

2025 · 1 entry · €1.1m awarded · €608,000 paid
Schemes
1 entry · €1.1m · €608,000 paid · Fonds voor Innoveren en Ondernemen

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.